Table 3.
Study Subject Details
| CD (n = 24) | HC (n = 39) | |
|---|---|---|
| Mean age, y (SD) | 42 (16) | 42 (14) |
| Male, % | 33 | 31 |
| Caucasian, % | 88 | 97 |
| Mean BMI (SD) | 27 (7) | 27 (5) |
| On aminosalicylate, % | 38 | 0 |
| On glucocorticoid, % | 38 | 0 |
| On immunomodulator, % | 54 | 0 |
| On anti-integrin, % | 8 | 0 |
| On anti-TNF, % | 67 | 0 |
| Bionaïve, % | 25 | 100 |
| OmpC seropositive, % | 33 | 0 |
| OmpC seronegative, % | 33 | 0 |
| OmpC unknown, % | 33 | 100 |
BMI, body mass index; TNF, tumor necrosis factor.